Description

BPC-157 | High Purity Research Peptide Online EU

BPC-157, or Body Protection Compound-157, is a synthetic pentadecapeptide consisting of 15 amino acids. This stable gastric peptide is native to human gastric juice and has been extensively studied for its cytoprotective and regenerative properties in research settings. As a leading peptide supplier Spain and across Europe, Euresearchpeptides.com offers premium BPC-157 for laboratory research applications. Buy BPC-157 Peptide Online EU

This high-purity research peptide is strictly intended for in vitro and in vivo laboratory studies only. Researchers across Germany, France, the Netherlands, and throughout the EU trust our buy peptides EU platform for consistent quality and reliable delivery. Buy BPC-157 Peptide Online EU

Visit our homepage at euresearchpeptides.com to explore our complete catalog of high purity peptides Germany and research chemicals EU compliant products.

Purity Specifications & Analytical Data

Every batch of BPC-157 from Euresearchpeptides.com undergoes rigorous quality control testing:

• HPLC Purity: ≥99.0% (individual batch COA provided)

• Mass Spectrometry: Confirmed molecular ion peak at m/z 1419.55

• Amino Acid Analysis: Within ±10% of theoretical composition

• Residual Solvents: Meets ICH Q3C guidelines

• Heavy Metals: <20 ppm

• Microbial Limits: No bacterial or fungal growth detected

• Endotoxin: Passes LAL test at <1.0 EU/mg

Each shipment includes a Certificate of Analysis with full HPLC chromatogram and MS spectra. For laboratory peptides Netherlands research, this documentation is essential for publication and protocol validation.

---

Solubility & Reconstitution Guidelines

Solubility Profile

Step-by-Step Reconstitution Protocol

For researchers studying peptides for research France applications:

1. Allow the lyophilized BPC-157 vial to reach room temperature (15-25°C) for 15 minutes before opening

2. Prepare sterile work surface and clean rubber stopper with alcohol pad

3. Calculate required diluent volume using the formula:

   • Desired concentration (mg/mL) = Peptide mass (mg) ÷ Diluent volume (mL)

   • Example: 5mg BPC-157 + 2mL bacteriostatic water = 2.5mg/mL

4. Using a sterile 1mL syringe, inject diluent slowly down the inner glass wall

5. Do not inject directly onto the peptide pellet

6. Gently swirl the vial until complete dissolution

7. Avoid vigorous shaking or vortexing as this may cause aggregation

For research SARMs and peptide combination studies, always reconstitute each compound separately before combining.

---

Stability Data & Storage Recommendations

Long-Term Storage (Lyophilized Powder)

Reconstituted Solution Stability

Best Practices for BPC-157 Europe Research

• Store lyophilized peptide in original packaging with desiccant

• Avoid repeated freeze-thaw cycles of reconstituted solutions

• Aliquot reconstituted BPC-157 into single-use volumes before freezing

• Label each vial with concentration, date of reconstitution, and researcher initials

• Discard if solution appears cloudy or contains visible particles

---

Known Research Applications & Citations

Gastrointestinal Research

BPC-157 demonstrates significant cytoprotective effects in gastrointestinal research models. Studies indicate that BPC-157 therapy promotes healing of various GI tract lesions and maintains mucosal integrity . Research applications include:

• Inflammatory bowel disease models

• Ulcerative colitis research (Phase II clinical trials completed)

• NSAID-induced gastrointestinal damage studies

• Leaky gut syndrome investigations

Neuropharmacology & Gut-Brain Axis

Recent research highlights BPC-157’s modulatory effects on the gut-brain axis. A 2026 comprehensive review published in Annales Academiae Medicae Silesiensis documented that BPC-157 exhibits pronounced cytoprotective, anti-inflammatory, and regenerative properties in preclinical models, enhancing neuronal survival and promoting synaptic plasticity.

Key findings include:

• Modulation of dopaminergic, serotonergic, and GABAergic pathways

• Improved motor coordination and cognitive performance in animal models

• Counteraction of Parkinson’s disease-like and Alzheimer’s disease-like disturbances

• Neurotransmitter system regulation (dopamine, serotonin, glutamate, GABA)

Angiogenesis & Wound Healing Research

BPC-157 controls angiogenesis and nitric oxide system healing functions without promoting pathological neovascularization. Research demonstrates:

• Advanced healing of transected Achilles tendon

• Regeneration of transected or crushed skeletal muscle

• Maintenance of corneal transparency while opposing pathological neovascularization

• Resolution of cornea “angiogenic privilege”

Hepatology & Portal Hypertension

Studies demonstrate BPC-157’s capacity to reverse liver cirrhosis and counteract portal hypertension in chronic alcohol administration models. Research applications include:

• Liver lesion prevention and reversal

• Portal pressure normalization

• Hepatocyte morphology recovery

Safety Profile

Toxicology studies have not established a lethal dose (LD1 not achieved), indicating an exceptionally high safety margin in research models. Beagle dog studies at 10 mg/kg intramuscular showed no distinct adverse effects . However, all products are for research use only and not approved for human consumption.

---

Handling Protocols & Safety Considerations

Required Safety Equipment

• Powder-free nitrile gloves

• Safety goggles

• Laboratory coat

• Biosafety cabinet (recommended for reconstitution)

• Sharps container for needle disposal

Reconstitution Safety Protocol

1. Perform all procedures in a designated laboratory area

2. Never pipette reconstituted solutions by mouth

3. Avoid skin contact with peptide solutions

4. In case of skin contact, wash immediately with soap and water

5. For eye exposure, rinse with water for 15 minutes and seek medical attention

6. Decontaminate spills with 10% bleach solution

For Research chemicals EU compliant laboratories:

• Document all handling procedures in laboratory notebook

• Follow institutional chemical hygiene plan

• Dispose of unused peptide as chemical waste per local regulations

• Used needles and syringes: sharps container

---

Why Choose Euresearchpeptides.com

As a premium UE-based online retailer specializing in peptide synthesis Europe, we deliver:

Our customers include research institutions, laboratories, and qualified researchers across Germany, France, Netherlands, Spain, Italy, Belgium, Austria, Switzerland, Sweden, and Denmark.

---

 FAQ Section

Q1: Where can I buy high purity BPC-157 for research in Europe?

You can purchase BPC-157 directly from euresearchpeptides.com, a trusted buy peptides EU supplier with warehouse operations across Europe. We offer verified 99%+ purity with Certificate of Analysis included. Order BPC-157 now

Q2: What is the molecular weight and sequence of BPC-157?

BPC-157 has a molecular weight of 1419.55 g/mol with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. This 15-amino acid pentadecapeptide is stable in gastric juice and extensively studied for cytoprotective properties. View specifications

Q3: How should I store BPC-157 for long-term research use?

Store lyophilized BPC-157 at -20°C (±5°C) for maximum stability up to 24 months. Reconstituted solutions should be refrigerated at 2-8°C and used within 30 days. For high purity peptides Germany research, avoid repeated freeze-thaw cycles. Storage guide

Q4: What is the recommended reconstitution protocol for BPC-157?

Reconstitute BPC-157 with sterile water or bacteriostatic water by injecting diluent slowly down the inner vial wall. Gently swirl until dissolved. Do not shake vigorously. Calculate concentration as peptide mass divided by diluent volume. For peptides for research France applications, 2mL diluent per 5mg peptide yields 2.5mg/mL. Reconstitution protocol

Q5: Is BPC-157 stable for oral administration in research models?

Yes, BPC-157 is uniquely stable in gastric juice for more than 24 hours, making it suitable for per-oral administration in research studies. This distinguishes it from many other research peptides that require parenteral administration. Research applications

Q6: What purity level does your BPC-157 have?

All BPC-157 from Euresearchpeptides.com is tested at ≥99% purity by HPLC-MS. Each shipment includes a Certificate of Analysis with individual batch testing data. As a leading laboratory peptides Netherlands supplier, we guarantee consistent quality. View COA example

Q7: What are the primary research applications for BPC-157?

BPC-157 is studied for gastrointestinal protection, neuropharmacology (gut-brain axis), wound healing, angiogenesis regulation, tendon and muscle healing, liver protection, and neurotransmitter system modulation . Learn more

Q8: Do you ship BPC-157 to my country in Europe?

We ship to all EU member countries including Germany, France, Netherlands, Spain, Italy, Belgium, Austria, Switzerland, Sweden, Denmark, and more. As a premier peptide supplier Spain and across Europe, orders typically arrive within 3-7 business days. Check shipping

Q9: Is BPC-157 compliant with EU research chemical regulations?

Yes. Euresearchpeptides.com operates as a research chemicals EU compliant supplier. All products are for laboratory research use only and not for human consumption. Documentation available for institutional review. Compliance info

Q10: What is the safety profile of BPC-157 in research studies?

Toxicology studies have not established a lethal dose (LD1 not achieved), indicating an exceptionally high safety margin. Beagle dog studies at 10 mg/kg showed no adverse effects. However, all products are for research use only and not approved for human consumption. Safety data

---

Product Citations & References

1. Pietrzyk B. BPC-157 and the gut–brain axis: emerging links between cytoprotection and neuroregeneration. Ann. Acad. Med. Siles. 2026; 80:42-50.

2. Sikiric P, et al. BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide’s Cytotoxic and Damaging Actions. Pharmaceuticals. 2025;18(10):1450.

3. Sikiric P, et al. Novel Cytoprotective Mediator, Stable Gastric Pentadecapeptide BPC 157. Vascular Recruitment and Gastrointestinal Tract Healing. Curr Pharm Des. 2018;24(18).

4. Sikiric P, et al. The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity. Pharmaceuticals. 2024;17(4):461.

5. Sikiric P, Rucman R, et al. Stable gastric pentadecapeptide BPC 157 in rat model. J Physiol Paris. 2001;95(1-6).

6. Józwiak M, et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review. Pharmaceuticals. 2025;18(2):185.

7. Pflaum Z, Rucman R. Solid Phase Peptide Synthesis of the Fragment BPC 157. Acta Chim Slov. 2005;52(1):34.